Combined hypoprothrombinemia-antiphospholipid syndrome in a patient suffering from lupus [1];Association hypoprothrombinémie-syndrome des antiphospholipides chez un patient lupique

Presse Medicale

Volumn 33, Issue 6, 2004, Pages 391-

  Sellami, Mona ^a   Elloumi, Mohammed ^a   Fourati, Hèla ^a   Ayadi, Nada ^a   Baklouti, Sofiène ^a  

^a HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DNA ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CLINICAL EXAMINATION; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOPROTHROMBINEMIA; LETTER; PATHOPHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 1942475296     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98603-4     Document Type: Letter

References (5)

1. Eberhard A, Sparling C, Sudbury S, Ford P, Laxer R, Silverman E. Hypoprothrombinemia in childhood systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24: 12-18.
2. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61: 684-92.
3. de Groot PG, Horbach DA, Simmelink MJ, van Oort E, Dersken RH. Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant. Lupus 1998; Suppl 2: S32-6.
4. Grau E, Real E, Pastor E, Ivorra J, Quecedo E. Prothrombin deficiency and hemorrhage associated with a lupus anticoagulant. Am J Hematol 1997; 54: 85.
5. Williams S, Linardic C, Wilson O, Comp P, Gralenik HR. Acquired hypoprothrombinemia: effects of danazol treatment. Am Hematol 1996; 53: 272-6.